Allogeneic Hematopoietic Stem Cell Transplantation forElderly Acute Lymphoblastic Leukemia Patients: A RegistryStudy From the Société Francophone de Greffe de Moelle etThérapie Cellulaire (SFGM-TC)

Chalandon Y, Devillier R, Boumendil A, Nguyen S, Bulabois CE, Ceballos P, Brissot E, Rubio MT, Labussière-Wallet H, Maertens J, Chevallier P, Maillard N, Poiré X, Castilla-Llorente C, Beguin Y, Cornillon J, Maury S, Marchand T, Daguindau E, Bay JO, Turlure P, Joris M, Menard AL, Bilger K, Guillerm G, François S, Bazarbachi A, Chantepie S, Lewalle P, Marçais A, Loschi M, Benakli M, Chauvet P, Forcade E, Huynh A, Robin M, Masouridi-Levrat S. American Journal of Hematology. 2025 April 19

Identification of the conditions and minimum requirements necessary for the release of autologous fresh CAR T-cell products under hospital exemption: a position paper from the WP-bioproduction of the UNITC consortium

Boyer O, Bensoussan D, Bönig H, Chabannon C, Clémenceau B, Cuffel A, Dachy G, de Vos J, Derenne S, Diana JS, Dougé A, Deramoudt L, Ferrand C, Forcade E, Galaine J, Galy A, Giverne C, Martinet J, Marton C, Larghero J, Reppel L, Viel S, Yakoub-Agha I, Deschamps M.Bone Marrow Transplant. 2025 Jan 25

Setting up haploidentical hematopoietic cell transplantation in low- and middle-income countries: The Recommendations of the Francophone Society of Bone Marrow and Cellular Therapy (SFGM-TC)

Hamzy F, Chevallier P, Bruno B, Coiteux V, El Kababri M, Ibrahim A, Oudrhiri A, Yakoub-Agha I, Bekadja MA.Bull Cancer. 2025 Jan;11

Medical simulation training for bone marrow harvesting from a healthy donor for an allogeneic hematopoietic cell transplant (SFGM-TC)

Alsuliman T, Magro L, Titecat M, Robin M, Kanouni T, Forcade E, Jubert C, Yakoub-Agha I, Faucher C.Bull Cancer. 2024 Dec 12

Sexual and emotional life among patients with hematological malignancy-Special concerns in low- and middle- income countries (LMICs)

Alsuliman T, Musiu P, AlAsadi L, Aljarad Z, Marjanovic Z, Beitinjaneh A, Garidi R.Curr Res Transl Med. 2024 Nov 26

Incidence and risk factors of graft failure in allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis in a nationwide pediatric cohort. A study on behalf of the SFGM-TC

Danhardt L, Wiedemann A, Michel G, Dalle JH, Rialland F, Renard C, Jubert C, Maertens J, Sirvent A, Buchbinder N, Devalck C, Brichard B, Paillard C, Nguyen S, Paci A, Combarel D, Castelle M, Pagliuca S, Pochon C.EJHaem. 2024 Nov 26

Assessing acute toxicity profiles of HLA-identical hematopoietic stem cell transplantation in pediatric patients with sickle cell anemia: A comprehensive analysis on behalf of the SFGM-TC

Delafoy M, Dalle JH, Pondarre C, Andrieu GP, Fahd M, Yakouben K, Castelle M, Koehl B, Neven B, Grain A; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire. Am J Hematol. 2024 Sep 24

Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma)

Tournilhac O, Altmann B, Friedrichs B, Bouabdallah K, Leclerc M, Cartron G, Turlure P, Reimer P, Wagner-Drouet E, Sanhes L, Houot R, Roussel M, Kroschinsky F, Dreger P, Viardot A, de Leval L, Rosenwald A, Gaulard P, Wulf G, Villate A, Latiere C, Elmaagacli A, Glass B, Poeschel V, Damaj G, Sibon D, Durot E, Bilger K, Banos A, Haenel M, Dreyling M, Keller U, Tiab M, Drenou B, Cornillon J, Nguyen S, Robin M, Nickelsen M, Trümper L, Lenz G, Ziepert M, Schmitz N; French Lymphoma Study Association (LYSA); Société Francophone de greffe de moelle et Thérapie Cellulaire (SFGM-TC); German Lymphoma Alliance (GLA); French Lymphoma Study Association (LYSA), Société Francophone de greffe de moelle et Thérapie Cellulaire (SFGM-TC), German Lymphoma Alliance (GLA).J Clin Oncol. 2024 Sep 13

Preventing relapse of acute leukemias and myelodysplastic syndromes in post-allograft transplantation: Prophylactic and preemptive strategies (SFGM-TC)

Coiteux V, Abellan I, Ahmad I, Boisnard A, Busquet C, Ceballos P, Coman T, Godin S, Hermet É, Marcais A, Mamez AC, Quessar A, Souchet L, Magro L, Simon N.Bull Cancer. 2024 Sep 5

Clinical and transversal competencies of advanced practice nurses (APNs) within a cellular therapy team (SFGM-TC)

Jezequel T, Ajazi Hub R, Bompoint C, Chauvel C, Colonnese E, Corbineau C, Desmedt C, Kicki C, Lomazzi S, Sirvent A, Evard S, Roux K, Magro L, Colledani F.Bull Cancer. 2024 Sep 5

Place of hematopoietic stem cell transplantation for very high risk acute myeloblastic leukemia and myelodysplastic syndromes (SFGM-TC)

Mediavilla C, D’Aveni M, Huynh A, Joris M, Masouridi-Levrat S, Nguyen S, Turlure P, Magro L, Guillaume T.Bull Cancer. 2024 Sep 5

Prerequisite and organisation of health-care pathways for Cell and Gene therapies, using Mesenchymal Stromal Cells (MSC) or Chimeric Antigen Receptor (CAR) T cells, in patients with autoimmune systemic diseases

Castilla-Llorente C, Bonnin A, Lansiaux P, Tudesq JJ, Beuvon C, Fabreguettes JR, Pers YM, Pugnet G, Maria ATJ, Puyade M, Urbain F, Terriou L, Poindron V, Jachiet M, Cacciatore C, Lescoat A, Prata PH, Munia I, Madelaine I, Thieblemont C, Tarte K, Yakoub-Agha I, Magro L, Farge D, Marjanovic Z.Bull Cancer. 2024 Sep 5

Acquired severe aplastic anemia in emerging countries: Management from allogeneic hematopoietic cell transplantation indication until post-transplant follow-up SFGM-TC

Yafour N, Bekadja MA, El Bejjaj I, Cheikh JE, El Kababri M, Magro L, Hamzy F.Bull Cancer. 2024 Sep 2

Long-term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and Belgium

Flore Sicre de Fontbrune, Florian Chevillon, Mony Fahd, Kristell Desseaux, Xavier Poiré, Edouard Forcade, Arthur Sterin, Bénédicte Neven, Virginie Gandemer, Sylvain Thepot, Alice Garnier, Bruno Lioure, Ambroise Marcais, Stephanie Nguyen-Quoc, Suzanne Tavitian, Laure Vincent, Jean Donadieu, Matthieu Resche Riggon, Sylvie Chevret, Marlene Pasquet, Regis Peffault de Latour.BJHaem. 2024 Aug 19

Alemtuzumab-based conditioning regimen before hematopoietic stem cell transplantation in patients with short telomere syndromes: a retrospective study of the SFGM-TC

Hussein-Agha R, Kannengiesser C, Lainey E, Marcais A, Srour M, Sterin A, Buchbinder N, Borie R, Plessier A, Socié G, Peffault de Latour R, Sicre de Fontbrune F.Bone Marrow Transplant. 2024 Jul 30

Pre-, per- and post-allogeneic haematopoietic stem cell transplant rehabilitation (Atelier SFGM-TC)

Pinelli V, Christophe L, Cheron N, Morin S, Gilis L, Heuze C, Clerc-Renaud D, Morotti L, Vilhet B, Bissardon S, Magro L. Bull Cancer. 2024 Jul 8

Childhood myelodysplastic syndromes: Is cytoreductive therapy useful before allogeneic hematopoietic stem cell transplantation?

Le Calvez B, Jullien M, Dalle JH, Renard C, Jubert C, Sterin A, Paillard C, Huynh A, Guenounou S, Bruno B, Gandemer V, Buchbinder N, Simon P, Pochon C, Sirvent A, Plantaz D, Kanold J, Béné MC, Rialland F, Grain A; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM‐TC). Hemasphere. 2024 Jul 8

Preventive and therapeutic strategies for relapse after hematopoietic stem cell transplant for pediatric AML (SFGM-TC)

Renard C, Corbel A, Paillard C, Pochon C, Schneider P, Simon N, Buchbinder N, Fahd M, Yakoub-Agha I, Calvo C. Bull Cancer. 2024 Jun 25

Diet guidelines in adult and pediatric patient after allogeneic stem cell transplantation (SFGM-TC)

Farrugia C, Lhostette A, Brasseur M, Biot T, Calmes H, Dendoncker C, Dupret AS, Estheve S, Filiol S, Guidi V, Hadrot L, Perez M, Ravinet A, Tardieu L, Magro L, Alfandari S, Simon N, Guenounou S, Cornillon J. Bull Cancer. 2024 Jun 25

EMERGINCaRE, le dispositif d’horizon scanning dédié aux médicaments anticancéreux développé par l’Institut national du cancerEMERGINCaRE, the horizon scanning system for anticancer drugs of the French National Cancer Institute

Duperray M, Bertin C, Sagot L, Breton T, Ifrah N. Bull Cancer. 2024 Jun 24

Publications